Literature DB >> 427402

Value of 1-alpha-hydroxy vitamin D3 in treatment of primary hyperparathyroidism before parathyroidectomy.

D A Heath, W Van't Hoff, A D Barnes, J G Gray.   

Abstract

The postoperative course of six patients with primary hyperparathyroidism and obvious radiological evidence of bone disease pretreated with 1-alpha-hydroxy vitamin D3 (1 alpha HCC) was indistinguishable from that of six patients with a similar clinical and radiological picture who were not pretreated. 1alphaHCC may increase the hypercalcaemia in some cases and cannot be recommended for the routine preparation of such patients for surgery.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 427402      PMCID： PMC1597771          DOI： 10.1136/bmj.1.6161.450

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  2 in total

Review 1.  Primary hyperparathyroidism.

Authors:  L N Pyrah; A Hodgkinson; C K Anderson
Journal:  Br J Surg       Date:  1966-04       Impact factor: 6.939

2.  1alpha-hydroxyvitamin D3 in primary hyperparathyroidism.

Authors:  I T Boyle; I Fogelman; B Boyce; J E Thomson; G H Beastall; W B McIntosh; I McLennan
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478
  2 in total
  2 in total

1.  Preoperative zoledronic acid therapy prevent hungry bone syndrome in patients with primary hyperparathyroidism.

Authors:  Sabaretnam Mayilvaganan; H A Vijaya Sarathi; C Shivaprasad
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

2.  A case of adolescent giant parathyroid adenoma presenting multiple osteolytic fractures and postoperative hungry bone syndrome.

Authors:  Kosuke Ebina; Yuji Miyoshi; Shinji Izumi; Jun Hashimoto; Norifumi Naka; Yasunori Tsukamoto; Masafumi Kashii; Takashi Kaito; Hideki Yoshikawa
Journal:  Clin Case Rep       Date:  2015-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.